Overview

Mobilise D is a consortium of academia, pharma and MedTech companies that come together to move forward development and integration of digital mobility assessments (also known as digital measures or digital biomarkers) in non-interventional and interventional clinical trials. We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you. Regulatory and Analytical experts will share the overview of their involvement and their insights when working with Mobilise D consortium.

Who is this event intended for? Statisticians and Data Scientists in early and late clinical drug development, and post-marketing. Anyone who is interested to learn more about digital measures development and integration in clinical trials.

What is the benefit of attending? Learn about challenges and possible solutions when developing and integrating digital measures/digital biomarkers in clinical development from experts in Regulatory and Data Science domains.

Timings

12:00-14:00 BST | 13:00-15:00 CEST